304 related articles for article (PubMed ID: 7639713)
1. Lysophospholipids activate ovarian and breast cancer cells.
Xu Y; Fang XJ; Casey G; Mills GB
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):933-40. PubMed ID: 7639713
[TBL] [Abstract][Full Text] [Related]
2. Effect of lysophospholipids on signaling in the human Jurkat T cell line.
Xu Y; Casey G; Mills GB
J Cell Physiol; 1995 Jun; 163(3):441-50. PubMed ID: 7775587
[TBL] [Abstract][Full Text] [Related]
3. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
5. Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
Park KS; Kim MK; Im DS; Bae YS
Biochem Pharmacol; 2007 Mar; 73(5):675-81. PubMed ID: 17161826
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Xu Y; Gaudette DC; Boynton JD; Frankel A; Fang XJ; Sharma A; Hurteau J; Casey G; Goodbody A; Mellors A
Clin Cancer Res; 1995 Oct; 1(10):1223-32. PubMed ID: 9815916
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.
Fischer DJ; Liliom K; Guo Z; Nusser N; Virág T; Murakami-Murofushi K; Kobayashi S; Erickson JR; Sun G; Miller DD; Tigyi G
Mol Pharmacol; 1998 Dec; 54(6):979-88. PubMed ID: 9855625
[TBL] [Abstract][Full Text] [Related]
8. A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells.
Lyons JM; Karin NJ
J Bone Miner Res; 2001 Nov; 16(11):2035-42. PubMed ID: 11697799
[TBL] [Abstract][Full Text] [Related]
9. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
[TBL] [Abstract][Full Text] [Related]
10. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
11. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.
Shen Z; Belinson J; Morton RE; Xu Y; Xu Y
Gynecol Oncol; 1998 Dec; 71(3):364-8. PubMed ID: 9887232
[TBL] [Abstract][Full Text] [Related]
12. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.
Fang X; Gaudette D; Furui T; Mao M; Estrella V; Eder A; Pustilnik T; Sasagawa T; Lapushin R; Yu S; Jaffe RB; Wiener JR; Erickson JR; Mills GB
Ann N Y Acad Sci; 2000 Apr; 905():188-208. PubMed ID: 10818454
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid receptor signaling in mammalian retinal pigment epithelial cells.
Thoreson WB; Ryan JS; Shi C; Kelly ME; Bryson EJ; Toews ML; Ediger TL; Chacko DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2450-61. PubMed ID: 12091450
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid-induced proliferation-related signals in astrocytes.
Keller JN; Steiner MR; Holtsberg FW; Mattson MP; Steiner SM
J Neurochem; 1997 Sep; 69(3):1073-84. PubMed ID: 9282930
[TBL] [Abstract][Full Text] [Related]
15. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
[TBL] [Abstract][Full Text] [Related]
16. Positive and negative controls by protein kinases of sodium-dependent Ca2+ efflux from cultured bovine adrenal chromaffin cells stimulated by lysophosphatidic acid.
Tokumura A; Okuno M; Fukuzawa K; Houchi H; Tsuchiya K; Oka M
Biochim Biophys Acta; 1998 Jan; 1389(1):67-75. PubMed ID: 9443605
[TBL] [Abstract][Full Text] [Related]
17. Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway.
Chin TY; Chueh SH
Am J Physiol; 1998 Nov; 275(5):C1255-63. PubMed ID: 9814974
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation.
Mathieson FA; Nixon GF
Br J Pharmacol; 2006 Feb; 147(4):351-9. PubMed ID: 16402047
[TBL] [Abstract][Full Text] [Related]
20. Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts.
Desai NN; Carlson RO; Mattie ME; Olivera A; Buckley NE; Seki T; Brooker G; Spiegel S
J Cell Biol; 1993 Jun; 121(6):1385-95. PubMed ID: 8389770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
